Development and Validation of a Hypertension Prevalence Estimator Tool For Use in Clinical Settings

Ritchey, Matthew; Yuan, Keming; Gillespie, Cathleen; Zhang, Guangyu; Ostchega, Yechiam

doi:10.1111/jch.12746

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Development and Validation of a Hypertension Prevalence Estimator Tool For Use in Clinical Settings

Published Date:

Jan 05 2016

Publisher's site:

http://dx.doi.org/10.1111/jch.12746 New Site Icon

Source:

J Clin Hypertens (Greenwich). 18(8):750-761.

[PDF-228.93 KB]

Details:

Alternative Title:

J Clin Hypertens (Greenwich)

Personal Author:

Ritchey, Matthew ; Yuan, Keming ; Gillespie, Cathleen ; Zhang, Guangyu ; Ostchega, Yechiam ;

Description:

Health systems are well positioned to identify and control hypertension among their patients. However, almost one third of US adults with uncontrolled hypertension are currently receiving medical care and are unaware of being hypertensive. This study describes the development and validation of a tool that health systems can use to compare their reported hypertension prevalence with their expected prevalence. Tool users provide the number of patients aged 18 to 85 years treated annually, stratified by sex, age group, race/ethnicity, and comorbidity status. Each stratum is multiplied by stratum-specific national prevalence estimates and the amounts are summed to calculate the number of expected hypertensive patients. The tool's validity was assessed by applying samples from cohorts with known hypertension prevalence; small differences in expected vs actual prevalence were identified (range, -3.3% to 0.6%). This tool provides clinically useful hypertension prevalence estimates that health systems can use to help inform hypertension management quality improvement efforts.

Subject:

[+]

Pubmed ID:

26729615

Pubmed Central ID:

PMC4935656

Document Type:

Journal Article

Funding:

HHSN268201300048C/HL/NHLBI NIH HHS/United States ; HHSN268201300049C/HL/NHLBI NIH HHS/United States ; CC999999/Intramural CDC HHS/United States ; HHSN268201300047C/HL/NHLBI NIH HHS/United States ; HHSN268201300050C/HL/NHLBI NIH HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	NIHMS731934-supplement-Supp_FigureS1___Supp_TableS1-S2.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
	nihms731934.nxml	application/octet-stream
	nihms731934f1.gif	image/gif
	nihms731934f1.jpg	image/jpeg

No Related Documents.

You May Also Like:

Application of a Tool to Identify Undiagnosed Hypertension — United States, 2016

Personal Author:

Ciemins, Elizabeth L.; Ritchey, Matthew D.; Joshi, Vaishali V.; Loustalot, Fleetwood; Hannan, Judy; Cuddeback, John K.;

Published Date:

Jul 27 2018

Source:

MMWR Morb Mortal Wkly Rep. 67(29):798-802.

Description:

Approximately 11 million U.S. adults with a usual source of health care have undiagnosed hypertension, placing them at increased risk for cardiovascular events (1-3). Using data from the National Health and Nutrition Examination Survey (NHANES), CDC ...

File Type:

[PDF - 224.71 KB]
MMWR. Morbidity and mortality weekly report, Vol. 67, no. 29, July 27, 2018

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

July 27, 2018

Series:

MMWR. Morbidity and mortality weekly report ; v. 67, no. 29

Description:

Mumps Outbreaks at Four Universities — Indiana, 2016 (CE Available) / Mugdha Golwalkar, MPH; Brian Pope; Jill Stauffer, MS; et al. -- Application of a Tool to Identify Undiagnosed Hypertension — United States, 2016 / Elizabeth L. Ciemins, PhD; Ma...

File Type:

[PDF - 652.66 KB]
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool

Personal Author:

Lloyd-Jones, Donald M.; Huffman, Mark D.; Karmali, Kunal N.; Sanghavi, Darshak M.; Wright, Janet S.; Pelser, Colleen; Gulati, Martha; Masoudi, Frederick A.; Goff, David C.;

Published Date:

November 04 2016

Source:

J Am Coll Cardiol. 69(12):1617-1636

Description:

The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiol...

File Type:

[PDF - 1.51 MB]
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool

Personal Author:

Lloyd-Jones, Donald M.; Huffman, Mark D.; Karmali, Kunal N.; Sanghavi, Darshak M.; Wright, Janet S.; Pelser, Colleen; Gulati, Martha; Masoudi, Frederick A.; Goff, David C.;

Published Date:

Nov 04 2016

Source:

Circulation. 135(13):e793-e813.

Description:

The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiol...

File Type:

[PDF - 2.08 MB]
Development and Validation of a Tool for Assessing Glucose Impairment in Adolescents

Personal Author:

DuBose, Katrina D.; Cummings, Doyle M.; Imai, Satomi; Lazorick, Suzanne; Collier, David N.;

Published Date:

May 24 2012

Source:

Prev Chronic Dis. 9.

Description:

IntroductionChildhood obesity is associated with an increased risk for type 2 diabetes. Early identification of adolescents at risk for impaired fasting blood glucose may lead to earlier and more comprehensive evaluation and intervention. Because wid...

File Type:

[PDF - 240.75 KB]